Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
TARS:NASDAQ
Tarsus Pharmaceuticals Inc
$60.97
0.00%
(0.00) 1D
Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TARS...
Mkt. cap
2.59B
Avg. vol.
487.48K
Volume
3.00
52-wk high
$85.25
52-wk low
$38.51
EPS
-$1.59
Beta
0.63
Shares outstanding
42.56M
No. of employees
370
News stories
From sources across the web
About Tarsus Pharmaceuticals Inc
CEO-
Employees370
Founded2016
HeadquartersIrvine, California, United States
SectorPharmaceutical industry
Next call in 6 days
Thu, Apr 30, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.26 est.)USD
Revenue / Estimate
-/ (153.52M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
78.34M
102.66M
118.70M
151.67M
Cost of goods sold
19.62M
21.83M
24.59M
28.96M
Cost of revenue
19.62M
21.83M
24.59M
28.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.00M
103.01M
108.63M
130.68M
Operating expense
85.00M
103.01M
108.63M
130.68M
Total operating expenses
104.62M
124.84M
133.23M
159.64M
Operating income
-26.28M
-22.18M
-14.53M
-7.98M
Other non operating income
-1.40M
-145.00K
98.00K
4.48M
EBT including unusual items
-25.12M
-20.34M
-12.58M
-6.31M
EBT excluding unusual items
-26.43M
-20.34M
-12.58M
-1.76M
Income tax expense
-
-
-
2.06M
Effective tax rate
-
-
-
-32.61%
Other operating expenses
-
-
-
-
Net income
-25.12M
-20.34M
-12.58M
-8.37M
Net profit margin
-32.07%
-19.81%
-10.60%
-5.52%
Earnings per share
-0.64
-0.48
-0.30
-0.20
Interest and investment income
3.45M
4.23M
4.11M
3.95M
Interest expense
-2.21M
-2.24M
-2.27M
-2.21M
Net interest expenses
1.24M
1.99M
1.85M
1.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.82M
-21.73M
-14.07M
-7.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more